A bestatin primes grapevine cells for augmented elicitation of the hypersensitive-like cell death and associated defense responses by methyl jasmonate
DOI:
https://doi.org/10.5073/vitis.2002.41.69-76Keywords:
Vitis vinifera L., Limberger, comet assay, proteases, apoptosis, protease inhibitors, , resveratrol, phenylalanine ammonia-lyaseAbstract
Localized treatment of grapevine (Vitis vinifera L. cv. Limberger) leaves with bestatin, an inhibitor of some aminopeptidases in plants and animals, augmented the sensitivity for methyl jasmonate-induced hypersensitive-like response. Enhanced resveratrol accumulation was associated with potentiated activation of genes encoding phenylalanine ammonia-lyase (PAL). The augmentation of PAL gene induction was proportional to the length of pretreatment with bestatin, indicating time-dependent printing of the cells. Exogenously supplied bestatin also potentiated other characteristic elicitor-induced short- and long-term defense responses in cell suspensions of grapevine including strong medium alkalinization and the production of reactive oxygen species (ROS), sequentially followed by defense gene activation and phytoalexin accumulation. Bestatin therefore appears to be exerting its effects close to the level of transcriptional control of defense-related genes, where it might inhibit a regulatory protease. Strikingly, the ability of bestatin to potentiate grapevine PAL gene elicitation and resveratrol accumulation, emphasizes an important role for defense response potentiation in acquired plant disease resistance.
Downloads
Published
Issue
Section
License
The content of VITIS is published under a Creative Commons Attribution 4.0 license. Any user is free to share and adapt (remix, transform, build upon) the content as long as the original publication is attributed (authors, title, year, journal, issue, pages) and any changes to the original are clearly labeled. We do not prohibit or charge a fee for reuse of published content. The use of general descriptive names, trade names, trademarks, and so forth in any publication herein, even if not specifically indicated, does not imply that these names are not protected by the relevant laws and regulations. The submitting author agrees to these terms on behalf of all co-authors when submitting a manuscript. Please be aware that this license cannot be revoked. All authors retain the copyright on their work and are able to enter into separate, additional contractual arrangements.